Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hyperlipoproteinemias

Free Subscription Articles published in Arterioscler Thromb Vasc Biol Retrieve available abstracts of 26 articles: HTML format

Single Articles

December 2025
1. D'ERASMO L, Tramontano D, Di Costanzo A, Casula M, et al
   Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.
   Arterioscler Thromb Vasc Biol. 2025;45:2264-2276.
   PubMed     Abstract available
   
   
   September 2025
2. WELLS AT, Bossardi Ramos R, Shen MM, Binrouf RH, et al
   Identification of Myeloid Protein Kinase C Epsilon as a Novel Atheroprotective Gene.
   Arterioscler Thromb Vasc Biol. 2025;45:e392-e411.
   PubMed     Abstract available
   
   
   July 2025
3. FARRA YM, Sabnis S, Matz J, Wilker H, et al
   Chronic Pod-Mod E-Cigarette Aerosol Exposure Induces Aortic Dysfunction in Hypercholesterolemic Mice: Role of Oxidative Stress and Inflammation.
   Arterioscler Thromb Vasc Biol. 2025 Jul 24. doi: 10.1161/ATVBAHA.125.320908.
   PubMed     Abstract available
   
   
   
4. GONZALEZ AL, Youwakim CM, Leake BF, Fuller KK, et al
   Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms Myelopoiesis.
   Arterioscler Thromb Vasc Biol. 2025;45:e286-e306.
   PubMed     Abstract available
   
   
   
5. LUSE MA, Schug WJ, Dunaway LS, Nyshadham S, et al
   Nitrosation of CD36 Regulates Endothelial Function and Serum Lipids.
   Arterioscler Thromb Vasc Biol. 2025;45:1067-1086.
   PubMed     Abstract available
   
   
   June 2025
6. AGUILAR V, Le Master E, Paul A, Ahn SJ, et al
   Endothelial Stiffening Induced by CD36-Mediated Lipid Uptake Leads to Endothelial Barrier Disruption and Contributes to Atherosclerotic Lesions.
   Arterioscler Thromb Vasc Biol. 2025;45:e201-e216.
   PubMed     Abstract available
   
   
   May 2025
7. WILKINSON MJ, Bijlani P, Davidson MH, Duell PB, et al
   Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective.
   Arterioscler Thromb Vasc Biol. 2025 May 29. doi: 10.1161/ATVBAHA.124.322364.
   PubMed     Abstract available
   
   
   January 2025
8. AMIOKA N, Franklin MK, Kukida M, Zhu L, et al
   Renal Proximal Tubule Cell-Specific Megalin Deletion Does Not Affect Atherosclerosis But Induces Tubulointerstitial Nephritis in Mice Fed a Western Diet.
   Arterioscler Thromb Vasc Biol. 2025;45:74-89.
   PubMed     Abstract available
   
   
   December 2024
9. GIANOS E, Duell PB, Toth PP, Moriarty PM, et al
   Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association.
   Arterioscler Thromb Vasc Biol. 2024;44:e304-e321.
   PubMed     Abstract available
   
   
   November 2024
10. TURKSON V, Haller A, Jaeschke A, Hui DY, et al
    ApoE Receptor-2 R952Q Variant in Macrophages Elevates Soluble LRP1 to Potentiate Hyperlipidemia and Accelerate Atherosclerosis in Mice.
    Arterioscler Thromb Vasc Biol. 2024 Nov 7. doi: 10.1161/ATVBAHA.124.321748.
    PubMed     Abstract available
    
    
    
11. BASHIR B, Downie P, Forrester N, Wierzbicki AS, et al
    Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.
    Arterioscler Thromb Vasc Biol. 2024;44:2334-2346.
    PubMed     Abstract available
    
    
    September 2024
12. CHAIX A, Lin T, Ramms B, Cutler RG, et al
    Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice.
    Arterioscler Thromb Vasc Biol. 2024;44:2069-2087.
    PubMed     Abstract available
    
    
    June 2024
13. VERGES B, Vantyghem MC, Reznik Y, Duvillard L, et al
    Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy.
    Arterioscler Thromb Vasc Biol. 2024 Jun 20. doi: 10.1161/ATVBAHA.124.320774.
    PubMed     Abstract available
    
    
    
14. TANG SY, Lordan R, Meng H, Auerbach BJ, et al
    Differential Impact In Vivo of Pf4-DeltaCre-Mediated and Gp1ba-DeltaCre-Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice.
    Arterioscler Thromb Vasc Biol. 2024;44:1393-1406.
    PubMed     Abstract available
    
    
    May 2024
15. TRINDER M, Cermakova L, Ruel I, Baass A, et al
    Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 23. doi: 10.1161/ATVBAHA.123.320287.
    PubMed     Abstract available
    
    
    
16. BELIARD S, Saheb S, Litzler-Renault S, Vimont A, et al
    Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 2. doi: 10.1161/ATVBAHA.123.320609.
    PubMed     Abstract available
    
    
    March 2024
17. RAAL FJ, Hegele RA, Ruzza A, Lopez JAG, et al
    Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.
    Arterioscler Thromb Vasc Biol. 2024 Mar 28. doi: 10.1161/ATVBAHA.123.320268.
    PubMed     Abstract available
    
    
    November 2023
18. PAQUETTE M, Cariou B, Bernard S, Hegele RA, et al
    Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2023 Nov 30. doi: 10.1161/ATVBAHA.123.319957.
    PubMed     Abstract available
    
    
    
19. DUBNER AM, Lu S, Jolly AJ, Noble T, et al
    Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research-Brief Report.
    Arterioscler Thromb Vasc Biol. 2023;43:2223-2230.
    PubMed     Abstract available
    
    
    September 2023
20. GRATTON J, Humphries SE, Futema M
    Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report.
    Arterioscler Thromb Vasc Biol. 2023;43:1737-1742.
    PubMed     Abstract available
    
    
    August 2023
21. BERRY ASF, Jones LK, Sijbrands EJ, Gidding SS, et al
    Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2023 Aug 17. doi: 10.1161/ATVBAHA.123.319341.
    PubMed     Abstract available
    
    
    July 2023
22. MENG FH, Liu S, Xiao J, Zhou YX, et al
    New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol.
    Arterioscler Thromb Vasc Biol. 2023;43:1219-1233.
    PubMed     Abstract available
    
    
    June 2023
23. BEA AM, Larrea-Sebal A, Marco-Benedi V, Uribe KB, et al
    Contribution of APOE Genetic Variants to Dyslipidemia.
    Arterioscler Thromb Vasc Biol. 2023;43:1066-1077.
    PubMed     Abstract available
    
    
    May 2023
24. LEWIS EA, Muniz-Anquela R, Redondo-Angulo I, Gonzalez-Cintado L, et al
    Capacity for LDL (Low-Density Lipoprotein) Retention Predicts the Course of Atherogenesis in the Murine Aortic Arch.
    Arterioscler Thromb Vasc Biol. 2023;43:637-649.
    PubMed     Abstract available
    
    
    April 2023
25. MARMONTEL O, Abou-Khalil Y, Bluteau O, Cariou B, et al
    Additive Effect of APOE Rare Variants on the Phenotype of Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2023 Apr 27. doi: 10.1161/ATVBAHA.123.319146.
    PubMed     Abstract available
    
    
    
26. ARNDT L, Hernandez-Resendiz I, Moos D, Dokas J, et al
    Trib1 Deficiency Promotes Hyperlipidemia, Inflammation, and Atherosclerosis in LDL (Low-Density Lipoprotein) Receptor Knockout Mice.
    Arterioscler Thromb Vasc Biol. 2023 Apr 20. doi: 10.1161/ATVBAHA.122.318137.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.